http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100551531-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
filingDate 1998-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100551531-B1
titleOfInvention Nuclease activator in cancer cells
abstract The present invention relates to novel drugs that are effective in treating cancers containing double helix RNA, such as I n C n . Specifically, the present invention relates to a carrier prepared with 2-0- (2-diethylaminoethyl) carbamoyl-1,3-0-dioleoylglycerol, and a phospholipid as a main component, and I n · C n or mismatch. A nuclease activator in cancer cells containing a complex with I n · C n .
priorityDate 1997-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421327933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135537060
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107182
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87556944
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450325442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437083

Total number of triples: 42.